FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to tritium-labelled 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid of formula I 
.
EFFECT: obtaining a tritium-labelled analogue of a physiologically active compound which is used to correct a range of genetic disorders.
1 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| UNIFORMLY TRITIUM-LABELED 4,4-DIFLUORO-N-{(1S)-3-[3-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO[3,2,1]OCT-8-YL]-1-PHENYLPROPYL}CYCLOHEXANE CARBODIIMIDE | 2008 |
|
RU2368613C1 |
| TRITIUM HIGH-LABELED [H]-(E)-N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-8-METHYL-6-NONENEAMIDE | 2004 |
|
RU2268256C1 |
| UNIFORMIZED BY DIETERIUM AND TRITIUM 3-(1-METHYLPYRROLIDINE-2-YL) PYRIDINE | 2014 |
|
RU2620190C2 |
| TRITIUM-LABELED ACYL-COENZYME A | 2006 |
|
RU2305104C1 |
| 4-(2-AMINOETHYL)PYROCATECHOL UNIFORMLY LABELLED WITH DEUTERIUM OR TRITIUM USING NANODIAMOND POWDER | 2010 |
|
RU2422436C1 |
| UNIFORMLY TRITIUM-LABELLED (R)-(+)-[5-METHYL-3-(4-MORPHOLINYLMETHYL) -2,3-DIHYDRO-[1,4]OXAZINE[2,3,4-hi]-6-INDOLYL]-1-NAPHTHALINYLMETHANONE ACETATE | 2009 |
|
RU2404185C1 |
| 5-(1,1-DIMETHYLHEPTYL)-2-[5-HYDROXY-2-(3-HYDROXYPROPYL)CYCLOHEXYL]PHENOL UNIFORMLY LABELLED WITH TRITIUM | 2009 |
|
RU2398755C1 |
| UNIFORMLY MARKED WITH TRITIUM TILOSIN | 2008 |
|
RU2360896C1 |
| TRITIUM UNIFORMLY LABELED [H]-TRANS-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-3-OXO-1-CYCLOHEXENE-1-YL)-2,4,6,8-NONATETRAENIC ACID | 2006 |
|
RU2318806C1 |
| 2-METHYL-3-PHYTHYL-1,4-NAPHTHOQUINONE HIGHLY LABELED WITH TRITIUM | 2001 |
|
RU2190591C1 |
